ExodusPoint Capital Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

ExodusPoint Capital Management’s Portfolio HARP Stock Details HARP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,081	Closed	-$54K	–	2629
2022 Q1	$54K	Buy	+1,081	New	+$56K	﹤0.01%	2059
2021 Q4	–	Sell	-4,573	Closed	-$361K	–	2739
2021 Q3	$361K	Buy	+4,573	New	+$460K	﹤0.01%	1543
2021 Q2	–	Sell	-1,428	Closed	-$299K	–	2951
2021 Q1	$299K	Buy	+1,428	New	+$286K	﹤0.01%	1678

Other funds holding HARP

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ExodusPoint Capital Management's HARP Position: Q2 2022 in Review

ExodusPoint Capital Management sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q2 2022, closing a stake of 1,081 shares — an estimated $54K sold.

ExodusPoint Capital Management first reported a position in HARP in Q1 2021 and held it in 3 quarters. The position peaked at $361K in Q3 2021. 63 funds tracked by Wall St. Rank hold HARP as of Q2 2022.

ExodusPoint Capital Management reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
ExodusPoint Capital Management sold 1,081 Harpoon Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $54K.
ExodusPoint Capital Management first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
ExodusPoint Capital Management's Harpoon Therapeutics, Inc. Common Stock position peaked at $361K in Q3 2021.
63 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q2 2022.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.